Thrombolytic Therapy:
Authors:
- Gregory R. D. EvansGEGregory R. D. Evans
- Michael J. MillerMMMichael J. Miller
- Gregory P. ReeceGRGregory P. Reece
- Howard LangsteinHLHoward Langstein
- David ChangDCDavid Chang
- Stephen S. KrollSKStephen S. Kroll
- Bao WangBWBao Wang
- Geoffrey L. RobbGRGeoffrey L. Robb
- 1 June 2001
- journal article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 46 (6) , 601-604
Abstract
Thrombolytic agents have been demonstrated to improve free flap salvage in animal models. However, clinical evidence regarding their efficacy has been scant. The authors reviewed their experience with flap salvage using thrombolytic therapy in 1,733 free flaps from February 1990 to July 1998. Patients with intraoperative pedicle thrombosis were excluded from this review. Forty-one of the 55 free flaps that were reexplored emergently were identified as having pedicle thrombosis. Of these 41 flaps, 28 free flaps were salvaged (flap salvage group, 68%) and 13 free flaps failed (flap failure group, 32%). Thrombolytic therapy (urokinase in 7 patients, tissue plasminogen activator in 1 patient) was used in six flaps in the flap salvage group and two flaps in the flap failure group. Statistical analysis demonstrated no difference between the two groups with regard to thrombolytic therapy. There was also no difference between the two groups with regard to use of systemic heparin (100–500 U per hour) at the time of pedicle thrombosis or with regard to whether Fogarty catheters were used. Smoking, preoperative radiotherapy, and the use of interpositional vein grafts during initial flap reconstruction had no impact on the outcome of flap salvage. The flap salvage group was reexplored at a mean of 1.5 days compared with the flap failure group, which was reexplored at a mean of 4.2 days (p = 0.007). Early detection of pedicle thrombosis remains the most important factor in the salvage of free flaps. Although these numbers are small and definitive statements cannot be made, the role of thrombolytic agents in free flap salvage requires further clinical evaluation.Keywords
This publication has 25 references indexed in Scilit:
- A Review of 716 Consecutive Free Flaps for Oncologic Surgical Defects: Refinement in Donor-Site Selection and TechniquePlastic and Reconstructive Surgery, 1998
- A Prospective Study of Microvascular Free-Flap Surgery and OutcomePlastic and Reconstructive Surgery, 1998
- Timing of Pedicle Thrombosis and Flap Loss after Free-Tissue TransferPlastic and Reconstructive Surgery, 1996
- Improved Efficacy of Urokinase Further Prolongs Ischemic Skin-Flap SurvivalJournal of Reconstructive Microsurgery, 1995
- The Additive Beneficial Effect of Uw Solution and Urokinase on Experimental Microvascular Free-Flap SurvivalJournal of Reconstructive Microsurgery, 1993
- Combined Therapy with Antithrombotic Agents and Radical Scavengers for Reperfusion Injury of FlapsJournal of Reconstructive Microsurgery, 1991
- The use of urokinase in ischemic replanted extremities in ratsJournal of Bone and Joint Surgery, 1987
- Use of streptokinase for the salvage of a free flap: Case report and review of the use of thrombolytic therapyMicrosurgery, 1987
- The effects of streptokinase on ischemic flapsThe Journal of Hand Surgery, 1983
- Microvascular Fibrinolysis after Ischemia: Its Relation to Vascular Patency and Tissue SurvivalPlastic and Reconstructive Surgery, 1981